The comforting reading is that a profitable, debt-reducing compounder is raising money only for itself, no promoter cash-out. The honest reading is that the biggest use of that money is plugging a working-capital gap the business has not funded from its own cash in three years.
Well-cooked or rushed
Not rushed. Three profitable years. But read the shape. Revenue from operations is nearly flat, ₹296 Cr to ₹328 Cr to ₹349 Cr, up just about 6% in FY26, while profit after tax went from ₹7.5 Cr to ₹21 Cr to ₹27 Cr, with the big jump in FY25. The offer document confirms this is genuine margin expansion, not a one-off: gross margin rose steadily from 16.1% to 23.4% and operating margin from 7.1% to 15.2% over the period, with no other-income or tax trick behind it. Durable so far. The swing factor is the price of polymer resin, its main raw material.
What the company does
BLS makes custom polymer compounds, the plastic granules used to insulate and sheath wires and cables and to coat underground oil, gas and water pipelines (HDPE, MDPE, LLDPE, XLPE, PVC, HFFR and filling compounds). It sells mainly to Indian wire and cable makers and pipe-coating firms, with some exports to 13 countries. It runs one manufacturing facility in Goa, plus warehouses in Delhi and a godown in Bhiwandi. There is no order book, revenue is recurring compound supply to repeat customers.
The issue
| Item | Detail |
|---|---|
| Type | Book-built, 100% fresh issue |
| Size | ₹255 Cr |
| Offer for sale | Nil |
| Price band | ₹142 to ₹150 |
| Lot size, minimum | 100 shares, ₹15,000 |
| Dates | Open 27 Oct, close 29 Oct, list 3 Nov 2026 |
| Promoter holding | 98.53% to 71.53% |
| Anchors | ₹76.5 Cr (FPIs and AIFs) |
| Post-issue market cap | ₹930 Cr |
This is the clean part. There is no offer for sale, so no promoter or investor is selling a single share into the issue. All ₹255 Cr goes to the company.
Use of proceeds
This is the heart of any IPO, what the money is for. Because it is a 100% fresh issue, the full amount (less issue expenses) is deployed by the company:
| Use of net proceeds | Amount (₹ Cr) |
|---|---|
| Capex, expanding the Goa manufacturing facility | 77.56 |
| Funding working capital requirements | 89.50 |
| General corporate purposes | balance (capped at 25% of gross) |
The largest single use is working capital, ₹89.5 Cr. Keep that in mind for the next section, because it connects to the biggest flag in the whole issue.
Financials (restated, ₹ Cr)
| Metric | FY24 | FY25 | FY26 | Q1 FY27 |
|---|---|---|---|---|
| Revenue from operations | 296.36 | 328.44 | 349.43 | 107.03 |
| Operating margin | 7.1% | 12.1% | 13.3% | 15.2% |
| Profit after tax | 7.52 | 21.14 | 27.01 | 10.23 |
| Profit margin | 2.5% | 6.4% | 7.7% | 9.6% |
| Debt to equity | 2.05 | 1.11 | 0.56 | 0.61 |
| Return on net worth | 16.1% | 31.1% | 28.5% | 9.7% (Q) |
Follow the cash. The offer document discloses, as a top-ten risk factor, that the company had negative operating cash flow in each of the last three financial years and in the June 2026 quarter. Operating cash flow is the cash a business actually collects from its day-to-day work. So profit is rising on paper, but the cash is tied up in working capital and is not coming in. That is precisely why ₹89.5 Cr of the raise is earmarked for working capital. The IPO is partly funding a cash-conversion problem, not only growth.
Peers and pricing
The three listed peers named in the offer document, with the company alongside (peer financials for FY26, peer market caps approximate for Aug to Oct 2026, peer P/E as cited in the document on 12 Oct 2026):
| Company | Market cap (₹ Cr) | FY26 revenue (₹ Cr) | FY26 PAT (₹ Cr) | PAT margin | P/E (x) | RoNW | P/BV (x) |
|---|---|---|---|---|---|---|---|
| BLS Polymers (at ₹150) | 930 (post-issue) | 349 | 27.0 | 7.7% | 22.7 | 28.5% | ~7.1 |
| Kingfa Science & Tech | ~8,100 | 1,996 | 185.3 | 9.3% | 46.3 | 13.2% | 3.7 |
| Ddev Plastiks | ~2,900 | 2,948 | 202.0 | 6.9% | 13.0 | 19.9% | 2.0 |
| Plastiblends India | ~530 | 789 | 36.7 | 4.7% | 14.5% | 8.2% | 0.7 |
Three readings. On size, BLS is the smallest by far, ₹349 Cr of revenue against Ddev's ₹2,948 Cr and Kingfa's ₹1,996 Cr. On valuation, at about 22.7 times earnings and 2.7 times sales it sits well above the two cheap compounders, Ddev (13 times) and Plastiblends (14.5 times), and below Kingfa (46 times), and at about 7 times book it is the most expensive on assets in the group. On quality, it has the best return on net worth, 28.5%, which is the argument for the premium. There is no single dominant listed pure-play, Ddev leads on revenue and Kingfa on market cap. The grey-market premium implies a listing near ₹190, a market cap of about ₹1,179 Cr.
Market size
Per the CRISIL report cited in the offer document, the Indian polymer compounding market grew from about USD 5,967 million in 2019 to about USD 9,934 million in 2025 and is projected to reach about USD 16,507 million by 2031, a compound growth rate near 9%. BLS, with roughly ₹349 Cr (about USD 42 million) of revenue, is under 0.5% of a roughly USD 10 billion market, a small player with a long runway driven by power, telecom and fibre, renewables and water and gas pipeline infrastructure.
Red and amber flags
The headline flag is the negative operating cash flow in each of the last three years and in Q1. Alongside it: customer concentration, with the top five customers at about 53% and the top ten at about 67% of FY26 revenue, and product concentration, with about 81% of revenue from wire and cable compounds. The document also discloses some untraceable or incorrect corporate records, past instances of non-compliance under the Companies Act, and about 3.3 lakh shares held by 46 untraceable shareholders. Litigation is immaterial (tax matters against the company of about ₹78 lakh), and the auditors have raised no qualifications. The standing operational risk is a swing in polymer resin prices.
Verdict
A clean, all-fresh structure and a genuine multi-year margin improvement, but BLS is the smallest name in its peer group, priced richer than the cheap compounders at about 23 times earnings and 7 times book, justified only by a best-in-class 28% return on net worth. And the offer document shows it has not converted profit into cash for three years, with the largest use of the raise going to plug that working-capital gap, on a concentrated customer and product base. Good structure, real margins, priced for the quality, with a cash-flow catch.
Educational purposes only. Not investment advice. DYOR.
Sources: the BLS Polymers RHP and abridged prospectus (SEBI), with issue, GMP and subscription data from Chittorgarh and InvestorGain, and peer FY26 financials from company results coverage. Peer market caps are approximate and date-sensitive, and the offer document's peer P/E is as of 12 Oct 2026, so both are worth re-checking on the day.